Caigui Xiang

700 total citations
16 papers, 520 citations indexed

About

Caigui Xiang is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Caigui Xiang has authored 16 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Caigui Xiang's work include Inflammatory Bowel Disease (5 papers), Inflammasome and immune disorders (3 papers) and Mast cells and histamine (3 papers). Caigui Xiang is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Inflammasome and immune disorders (3 papers) and Mast cells and histamine (3 papers). Caigui Xiang collaborates with scholars based in China. Caigui Xiang's co-authors include Wei Tang, Heng Li, Chunlan Feng, Huimin Lu, Fan Chen, Jianping Zuo, Pei‐Lan He, Xiaoqian Yang, Bing Wu and Huimin Lu and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

Caigui Xiang

16 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caigui Xiang China	10	247	179	90	86	63	16	520
Shaowei Huang China	9	241 1.0×	88 0.5×	74 0.8×	89 1.0×	65 1.0×	18	479
Xiancai Zhong South Korea	15	226 0.9×	230 1.3×	78 0.9×	77 0.9×	34 0.5×	29	574
Feifei Nong China	10	300 1.2×	75 0.4×	115 1.3×	71 0.8×	75 1.2×	15	487
Qun Du China	14	349 1.4×	73 0.4×	91 1.0×	39 0.5×	43 0.7×	23	543
Fengyuan Chen China	12	227 0.9×	69 0.4×	71 0.8×	58 0.7×	28 0.4×	16	520
Lei Shen China	15	326 1.3×	196 1.1×	97 1.1×	26 0.3×	90 1.4×	30	707
Mingzhu Li China	13	332 1.3×	116 0.6×	42 0.5×	39 0.5×	27 0.4×	33	649
Jiuheng Yin China	12	245 1.0×	84 0.5×	66 0.7×	30 0.3×	26 0.4×	20	458
Xuehua Piao China	11	265 1.1×	123 0.7×	78 0.9×	28 0.3×	95 1.5×	15	520

Countries citing papers authored by Caigui Xiang

Since Specialization

Citations

This map shows the geographic impact of Caigui Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caigui Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caigui Xiang more than expected).

Fields of papers citing papers by Caigui Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caigui Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caigui Xiang. The network helps show where Caigui Xiang may publish in the future.

Co-authorship network of co-authors of Caigui Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Caigui Xiang. A scholar is included among the top collaborators of Caigui Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caigui Xiang. Caigui Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yang, Tao, Caigui Xiang, Xiaohan Wang, et al.. (2024). RIPK1 inhibitor ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells. Cell Death Discovery. 10(1). 152–152. 13 indexed citations

Zhang, Yao, Jia Liu, Caigui Xiang, et al.. (2024). Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis. Inflammatory Bowel Diseases. 30(4). 617–628. 13 indexed citations

Zhang, Yao, Caigui Xiang, Tao Yang, et al.. (2024). Methionine-choline deficient diet deteriorates DSS-induced murine colitis through disturbance of gut microbes and infiltration of macrophages. Acta Pharmacologica Sinica. 45(9). 1912–1925. 1 indexed citations

Xiang, Caigui, Heng Li, & Wei Tang. (2022). Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases. Pharmacological Research. 187. 106566–106566. 58 indexed citations

Xiang, Caigui, Fan Chen, Huimin Lu, et al.. (2022). Interfering with alternatively activated macrophages by CSF-1R inhibition exerts therapeutic capacity on allergic airway inflammation. Biochemical Pharmacology. 198. 114952–114952. 6 indexed citations

Xiang, Caigui, Fan Chen, Huimin Lu, et al.. (2021). Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis. Cellular Immunology. 365. 104364–104364. 26 indexed citations

Li, Heng, Yao Zhang, Fan Chen, et al.. (2021). Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis. Acta Pharmaceutica Sinica B. 12(1). 228–245. 27 indexed citations

Li, Bo, Heng Li, Zhengdan Zhu, et al.. (2021). Discovery of chiral N-2′-aryletheryl-1′-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazolinium. European Journal of Medicinal Chemistry. 222. 113583–113583. 1 indexed citations

Wu, Bing, Mengmeng Xu, Fan Chen, et al.. (2021). STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion. Acta Pharmacologica Sinica. 43(8). 2055–2066. 95 indexed citations

10.

Chen, Fan, Caigui Xiang, Bing Wu, et al.. (2021). Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells. Acta Pharmacologica Sinica. 43(2). 376–386. 7 indexed citations

11.

Xiang, Caigui, Xin Li, Fan Chen, et al.. (2021). Discovery of Potent Antiallergic Agents Based on an o-Aminopyridinyl Alkynyl Scaffold. Journal of Medicinal Chemistry. 64(18). 13588–13603. 1 indexed citations

12.

Li, Heng, Xianglei Zhang, Caigui Xiang, et al.. (2021). Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation. Journal of Advanced Research. 33. 241–251. 15 indexed citations

13.

Li, Heng, Chunlan Feng, Fan Chen, et al.. (2020). Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. Cell Death and Disease. 11(4). 271–271. 61 indexed citations

14.

Wu, Bing, Yingqiang Liu, Linjiang Tong, et al.. (2020). Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders. Journal of Medicinal Chemistry. 63(3). 1397–1414. 24 indexed citations

15.

Li, Heng, Fan Chen, Huimin Lu, et al.. (2019). Protective role of berberine on ulcerative colitis through modulating enteric glial cells–intestinal epithelial cells–immune cells interactions. Acta Pharmaceutica Sinica B. 10(3). 447–461. 170 indexed citations

16.

Xiang, Caigui & Xiao Cheng. (2009). ON A CLASS OF WEAKLY-BERWALD (ALPHA, BETA)-METRICS. 29. 227–236. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact